Formulation D
Formulation D is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants
Bioequivalence and Food Effect Study in Healthy Volunteers
Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
Clinical Trials (5)
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants
Bioequivalence and Food Effect Study in Healthy Volunteers
Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5